"Supportive care" may hold less stigma than "palliative care"
the ONA take:
Hematologic specialists were less likely to refer patients early in the disease trajectory to palliative care and were conducive to referral with the service name supportive care instead of palliative care, a new study published online ahead of print in the journal The Oncologist has shown.
Because palliative care referrals are often delayed for patients with hematologic malignancies, researchers sought to examine the differences in attitudes and beliefs toward palliative care referral between hematologic and solid tumor specialists and how their perception was altered with the service name supportive care instead of palliative care.
For the study, researchers surveyed 120 hematologic and 120 solid tumor oncology specialists at University of Texas MD Anderson Cancer Center in Houston, Texas.
Results showed that hematologic specialists were less likely than solid tumor specialists to report that they would refer symptomatic patients with newly diagnosed cancer to palliative care.
Researchers also found that a significantly greater proportion of oncology specialists reported that they would refer a patient with newly diagnosed cancer to supportive care than palliative care, even though they both provide the same service.
“These findings suggest that rebranding might help to overcome the stigma associated with palliative care and improve patient access to palliative care services,” the authors conclude.
Hematologic specialists were less likely to refer patients early in the disease trajectory to palliative care.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|